(Q38316118)

2 September 2017

title

Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides. (English)

1 reference

2 September 2017

Hatta T

1

1 reference

2 September 2017

Kim SG

2

1 reference

2 September 2017

Nakashima H

3

1 reference

2 September 2017

Yamamoto N

4

1 reference

2 September 2017

Sakamoto K

5

1 reference

2 September 2017

Yokoyama S

6

1 reference

2 September 2017

Takaku H

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

2 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

2 September 2017

volume

330

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

161-164

1 reference

Driving the cell cycle: M phase kinase, its partners, and substrates

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Control of ribonucleic acid function by oligonucleoside methylphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2893%2980264-U

10.1016/0014-5793(93)80264-U

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference